Are human induced pluripotent stem cell derived cardiomyocytes a good cellular model for studying incomplete penetrance in arrhythmogenic cardiomyopathy?
Event:
Frontiers in CardioVascular Biomedicine 2022
Massively parallel sequencing of patients affected with arrhythmogenic cardiomyopathy by a targeted gene panel identified a novel nonsense mutation in TP63 gene.
